An equal-weight ETF is exactly what it sounds like: a fund that allocates roughly the same percentage to each holding, regardless of company size. Instead of letting the largest firms dominate — as in traditional market-cap-weighted indices — each constituent begins at a similar weight, often around 4–5% in a concentrated sector.
To maintain that balance, the ETF periodically rebalances — trimming positions that have grown and adding to those that have declined. The result is a portfolio that continuously resets itself, rather than drifting toward its largest winners.
That shift brings both advantages and limitations.
Potential for Reduced Concentration Risk
In cap-weighted indices performance tends to hinge on a handful of dominant names, equal-weighting aims to redistribute that influence. This creates a portfolio that appears to be less dependent on the trajectory of a few mega-cap stocks, a consideration in healthcare, where outcomes can be binary.
A Rebalancing Mechanism
Equal-weight ETFs require periodic rebalancing to maintain their structure. This tends to result in the fund trimming positions that have appreciated and adding to those that have lagged. Over time, the intent is to create a systematic discipline that attempts to reduce the impact of market sentiment on the decision making process.
Sector Representation
Healthcare is not a monolith. Without constraints, cap-weighted approaches can become skewed toward dominant industries like large-cap pharmaceuticals. Equal weighting seeks to mitigate that drift, potentially preserving exposure across subsectors.
Mid-Cap Participation
Equal weighting ideally increases exposure to companies that sit just below mega-cap status. If a mid-sized firm delivers a breakthrough for example, the impact on an equal-weight ETF may appear more pronounced than in a cap-weighted index, where such companies often carry minimal weight.
The Trade-Offs to Consider
Maintaining equal weights requires regular rebalancing. This can lead to higher trading costs compared to certain passive, buy-and-hold strategies. It may also result in capital gains distributions, depending on the structure and the jurisdiction of the fund.
Market Momentum
Rebalancing may introduce discipline, but it tends to limit upside in certain environments. By trimming outperformers, equal-weight ETFs may reduce exposure to stocks that continue to rally. In markets where leadership remains narrow, this can create a performance gap relative to cap-weighted peers.
Volatility Exposure
Equal-weight strategies elevate the role of smaller constituents. While this aims to increase diversification, it also introduces a higher sensitivity to companies that may exhibit greater price volatility than established mega-caps. The result can be a more varied return profile.
Tracking Error
Equal-weight ETFs are not designed to mirror standard indices. Compared to benchmark indexes, performance can diverge — sometimes for extended periods. When large-cap names lead the market, equal-weight strategies tend to lag.
Conclusion
For investors, the decision isn’t about which structure is better. It’s about which aligns more closely with your objectives. Equal-weight ETFs like the Global X Equal Weight Global Healthcare Index ETF (MEDX:TSX) may offer breadth. Whether that trade-off is worthwhile depends on how you define risk — and how much of it you’re willing to concentrate in a single name.
Commissions, management fees and expenses all may be associated with an investment in products (the “Global X Funds”) managed by Global X Investments Canada Inc. The Global X Funds are not guaranteed, their values change frequently and past performance may not be repeated. The prospectus contains important detailed information about the Global X Funds. Please read the relevant prospectus before investing.
Certain statements may constitute a forward-looking statement, including those identified by the expression “expect” and similar expressions (including grammatical variations thereof). The forward-looking statements are not historical facts but reflect the author’s current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking statements. These forward-looking statements are made as of the date hereof and the authors do not undertake to update any forward-looking statement that is contained herein, whether as a result of new information, future events or otherwise, unless required by applicable law.
This communication is intended for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to purchase investment products (the “Global X Funds”) managed by Global X Investments Canada Inc. and is not, and should not be construed as, investment, tax, legal or accounting advice, and should not be relied upon in that regard. Individuals should seek the advice of professionals, as appropriate, regarding any particular investment. Investors should consult their professional advisors prior to implementing any changes to their investment strategies. These investments may not be suitable to the circumstances of an investor.
Global X Investments Canada Inc. (“Global X”) is a wholly-owned subsidiary of Mirae Asset Global Investments Co., Ltd. (“Mirae Asset”), the Korea-based asset management entity of Mirae Asset Financial Group. Global X is a corporation existing under the laws of Canada and is the manager, investment manager and trustee of the Global X Funds.
© 2026 Global X Investments Canada Inc. All Rights Reserved.